Gene · 1908
NIH grants1,222
NIH grants whose papers are about the gene, through NIH's grant-paper links.
181 to 200 of 1,222
Download this page as JSON| Grant | Title | EDN3 papers | Newest fiscal year |
|---|---|---|---|
| R01HL155611 | Tissue niches for ILC3 development in newborn's lung | 1 | 2024 |
| R01NS085770 | Concordance of TDP-43 Inclusions with Cortical Atrophy and Clinical Phenotype | 1 | 2024 |
| R21MH133001 | Identification of Distinct Biotypes in Clinical High Risk for Psychosis State Using Objective Brain-Based Biomarkers | 1 | 2024 |
| R25GM066526 | UofSC Postbaccalaureate Research Education Program | 1 | 2024 |
| R35GM138313 | Novel Bayesian statistical tools for integrating multi-omics data to help elucidate the genomic etiology of complex phenotypes | 1 | 2024 |
| T32CA009140 | Immunobiology of Normal and Neoplastic Lymphocytes | 1 | 2024 |
| U01AG032984 | Alzheimer's Disease Genetics Consortium | 1 | 2024 |
| U01AI150748 | Dynamic regulatory network models of human response to influenza virus | 1 | 2024 |
| U01HG007269 | IGNITE EP2 - Admin Supplement | 1 | 2024 |
| UL1TR001427 | Together: Transforming and Translating Discovery to Improve Health | 1 | 2024 |
| UM1HG011586 | UW 4-Dimensional Genomic Organization of Mammalian Embryogenesis Center | 1 | 2024 |
| T32GM007739 | Weill Cornell/Rockefeller/Sloan Kettering MST Program | 4 | 2023 |
| P01CA114046 | Targeted Therapies in Melanoma | 3 | 2023 |
| ZIAHG000070 | Analysis of Dominant Megacolon: Another Hirschsprung Disease Model | 3 | 2023 |
| R01CA122959 | CCAR2 as a Target for Prevention of Colorectal Cancer. | 2 | 2023 |
| U54NS115266 | Traumatic Brain Injury and Repetitive Head Impacts: Contributions to AD/ADRD and CTE Neuropathology and Resulting Clinical Syndromes | 2 | 2023 |
| ZIAHG000136 | Functional genomic analysis of neural crest development | 2 | 2023 |
| F30CA254152 | The role of lipids in melanoma progression via induction of ER stress and lipid droplet formation | 1 | 2023 |
| F31AI164870 | Multi-organ omic model for sepsis therapeutic development | 1 | 2023 |
| I01BX004613 | CTBI:CBI Tauopathy in Mice and Human: Neurodegeneration after Repetitive Neurotrauma: Mechanisms and Biomarker Discovery | 1 | 2023 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1908/grants?page=10